Trial intelligence / Profile preview

Dexmedetomidine for SVT in Non-cardiac Surgery

NCT04284150Unknown

Sponsor
First People's Hospital of Lianyungang City
Start
Feb 2020
Primary completion
Jun 2020
01

Overview

Randomised trial of dexmedetomidine in supraventricular tachycardia (SVT), sponsored by First People's Hospital of Lianyungang City. Primary endpoints: Dexmedetomidine treatment of supraventricular tachycardia at 6 months and Midazolam treatment of supraventricular tachycardia at 6 months. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

supraventricular tachycardia (SVT)

Beyond the preview

Go deeper on NCT04284150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04284150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call